Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-03-26 6:06 pm Sale | 2026-03-13 | 13G | DENALI THERAPEUTICS INC DNLI | VANGUARD GROUP INC | 0 0.000% | -10,834,483 (Position Closed) | Filing History |
| 2025-11-05 11:30 am Sale | 2025-09-30 | 13G | DENALI THERAPEUTICS INC DNLI | FMR LLC | 8,536,392 5.800% | -1,605,509 (-15.83%) | Filing History |
| 2025-08-12 10:34 am Sale | 2025-06-30 | 13G | DENALI THERAPEUTICS INC DNLI | WELLINGTON MANAGEMENT GROUP LLP | 5,664,733 3.900% | -5,062,717 (-47.19%) | Filing History |
| 2025-04-17 3:05 pm Sale | 2025-03-31 | 13G | DENALI THERAPEUTICS INC DNLI | BlackRock Inc. BLK | 10,490,610 7.200% | -5,887,420 (-35.95%) | Filing History |
| 2025-04-17 09:35 am Sale | 2025-03-31 | 13G | NUTANIX INC NTNX | BlackRock Inc. BLK | 16,378,030 6.100% | -3,198,468 (-16.34%) | Filing History |
| 2025-02-13 2:14 pm Sale | 2024-12-31 | 13G | DENALI THERAPEUTICS INC DNLI | Capital Research Global Investors | 5,477,211 3.800% | -2,431,903 (-30.75%) | Filing History |
| 2025-02-12 10:52 am Sale | 2024-12-31 | 13G | DENALI THERAPEUTICS INC DNLI | BAILLIE GIFFORD & CO | 12,313,931 8.600% | -1,946,793 (-13.65%) | Filing History |
| 2024-11-12 12:52 pm Purchase | 2024-11-07 | 13G | DENALI THERAPEUTICS INC DNLI | Capital Research Global Investors | 7,909,114 5.500% | 7,909,114 (New Position) | Filing History |
| 2024-11-12 09:55 am Purchase | 2024-11-08 | 13G | DENALI THERAPEUTICS INC DNLI | FMR LLC | 10,141,901 7.084% | 2,949,956 (+41.02%) | Filing History |
| 2024-11-08 5:31 pm Unchanged | 2024-09-30 | 13G | DENALI THERAPEUTICS INC DNLI | BlackRock Inc. BLK | 13,787,873 9.600% | 0 (Unchanged) | Filing History |
| 2024-11-08 10:52 am Purchase | 2024-09-30 | 13G | DENALI THERAPEUTICS INC DNLI | WELLINGTON MANAGEMENT GROUP LLP | 10,727,450 7.490% | 3,452,733 (+47.46%) | Filing History |
| 2024-11-07 4:48 pm Sale | 2024-10-30 | 13G | DENALI THERAPEUTICS INC DNLI | BIOGEN INC. BIIB | 7,155,243 4.970% | -5,596,122 (-43.89%) | Filing History |
| 2024-10-21 4:11 pm Purchase | 2024-09-30 | 13G | DENALI THERAPEUTICS INC DNLI | BlackRock Inc. BLK | 13,787,873 9.600% | 2,245,012 (+19.45%) | Filing History |
| 2024-08-16 1:18 pm Purchase | 2024-08-15 | 13G | DENALI THERAPEUTICS INC DNLI | FMR LLC | 7,191,945 5.023% | 1,337,910 (+22.85%) | Filing History |
| 2024-02-13 5:02 pm Purchase | 2023-12-29 | 13G | DENALI THERAPEUTICS INC DNLI | VANGUARD GROUP INC | 10,834,483 7.840% | 887,385 (+8.92%) | Filing History |
| 2024-02-13 4:27 pm Sale | 2023-12-31 | 13G | DENALI THERAPEUTICS INC DNLI | BRATTON DOUGLAS K | 5,750,882 4.200% | -1,250,000 (-17.85%) | Filing History |
| 2024-02-12 7:07 pm Sale | 2023-12-31 | 13G | DENALI THERAPEUTICS INC DNLI | BIOGEN INC. BIIB | 12,751,365 9.230% | -558,878 (-4.20%) | Filing History |
| 2024-02-08 10:11 am Purchase | 2023-12-29 | 13G | DENALI THERAPEUTICS INC DNLI | WELLINGTON MANAGEMENT GROUP LLP | 7,274,717 5.260% | 7,274,717 (New Position) | Filing History |
| 2024-01-30 06:59 am Sale | 2023-12-29 | 13G | DENALI THERAPEUTICS INC DNLI | BAILLIE GIFFORD & CO | 14,260,724 10.320% | -858,750 (-5.68%) | Filing History |
| 2024-01-30 06:40 am Unchanged | 2023-12-31 | 13G | DENALI THERAPEUTICS INC DNLI | Temasek Holdings (Private) Limited | 6,895,992 4.900% | 0 (Unchanged) | Filing History |